Las Vegas, NV -- (SBWIRE) -- 09/25/2013 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: Fab Universal Corp(NYSEMKT:FU), Arbor Realty Trust, Inc.(NYSE:ABR), GenVec Inc(NASDAQ:GNVC), Catalyst Pharmaceutical Partners, Inc.(NASDAQ:CPRX)
Fab Universal Corp(NYSEMKT:FU) ended higher +18.85% and complete the day at $9.27. The total number of shares changed hands during the day was 5.31 million. After opening at $8.44, the stock hit as high as $9.74. However, it traded between $2.25 and $9.74 over the last twelve months. FAB Universal Corp. engages in the distribution of digital entertainment products and services worldwide.
For How Long FU will Fight for Profitability? Read This Trend Analysis report
Arbor Realty Trust, Inc.(NYSE:ABR) closed yesterday at $6.90, a -5.48% decrease. Around 5.23 million shares were traded, beating an-average trading volume of 77,004.00 shares. The company is now valued at around $297.65 million. Arbor Realty Trust, Inc. operates as a real estate investment trust (REIT) in the United States.
Has ABR Found The Bottom And Ready To Gain Momentum? Find Out Here
GenVec Inc(NASDAQ:GNVC) moved +35.14 percent higher at $1.50 and traded between $1.13and $1.69 after opening the day at $1.15. Its performance over the last five days remained +26.04%, which stands at +434.95% for a month. Going back further than one month, 1-year performance after recent close was +11.94%. GenVec, Inc. operates as a biopharmaceutical company that uses differentiated and proprietary technologies to create therapeutics and vaccines.
Will GNVC Continue To Move Higher? Find Out Here
Catalyst Pharmaceutical Partners, Inc.(NASDAQ:CPRX)’s shares rose, gaining +7.32 percent to close at $3.08. The stock is up around +608.05% this year and +60.42% for the last 12 months. Around 4.28 million shares changed hands yesterday, higher from an-average trading volume of 2.88 million shares. Catalyst Pharmaceutical Partners, Inc. operates as development-stage specialty pharmaceutical company.
Why Should Investors Buy CPRX After The Recent Gain? Just Go Here and Find Out
Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks.
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)